MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Treatment"

  • 2019 International Congress

    Influence of the spinal manipulation on muscle spasticity: a randomized controlled trial

    L. Shestopalova, T. Voloshyn (Truskavets, Ukraine)

    Objective: To assess how spinal manipulation influences muscle tone of the limbs Background: Muscle spasticity is an important clinical syndrome of many diseases, namely Parkinsons, post-stroke,…
  • 2019 International Congress

    Improvement of lower extremity Holmes tremor with intrathecal baclofen: First Report

    S. Saad, C. Kilbane, H. Abboud (Cleveland, OH, USA)

    Objective: OBJECTIVE: To describe a novel response of Atypical Holmes tremor to intrathecal baclofen (ITB). Background: Holmes tremor is a rare low-frequency high-amplitude tremor predominantly…
  • 2019 International Congress

    Inspiring Neurology Residents to Select Movement Disorders Fellowship Training

    K. Harper, T. Davis, F. Phibbs, PD. Charles (Nashville, TN, USA)

    Objective: To measure the impact of a junior resident education course focused on common movement disorders. Background: Focus on Common Movement Disorders is a two-day…
  • 2019 International Congress

    Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study

    M. Rosário, J. Ferreira, J. Ferro, L. Guedes (Lisbon, Portugal)

    Objective: Study the effect of fampridine in gait outcomes in patients with hereditary spastic paraplegia (HSP). Background: Fampridine acts through blockade of voltage-gated potassium channels,…
  • 2019 International Congress

    Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia

    Y. Fan, G. Wali, R. Sutharsan, C. Sue, A. Mackay-Sim (Sydney, Australia)

    Objective: Identify a drug treatment for Hereditary Spastic Paraplegia (HSP) using patient-derived stem cell models Background: HSP is a neurological disorder characterised by axonal degeneration…
  • 2019 International Congress

    The statement about the effectiveness of non-medication methods in the complex treatment of spasticity of different genesis

    O.. Tondiy (Kharkiv, Ukraine)

    Objective: Considering polypragmasy and many side effects of drugs, the need for non-drug components of the treatment complex is always relevant. Background: The effect of…
  • 2019 International Congress

    Comparative Study of Dry Needling under Ultrasound Guidance and Extracorporeal Shock Wave Therapy for Myofascial Pain and Spasticity Management

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to conduct comparative study of using dry needling under ultrasound guidance vs ESWT for detecting MTrP and myofascial pain and spasticity…
  • 2019 International Congress

    OnabotulinumtoxinA treatment in adults with spasticity reduces caregiver burden: Results from the ASPIRE study

    A. Esquenazi, A. Ellenbogen, G. Wittenberg, K. Ngo, J. Largent, A. Zuzek, G. Francisco, W. Jost (Elkins Park, PA, USA)

    Objective: To examine the impact of onabotulinumtoxinA treatment in adult patients with spasticity on caregiver burden over 2 years from the Adult Spasticity International Registry…
  • 2018 International Congress

    “Appropriate Doses Treatment” of IncobotulinumtoxinA in spasticity

    G. Ianieri, R. Marvulli (Bari, Italy)

    Objective: The aim of this study is to object the efficiency and safety of 100 to 1000 units botulinum toxin treatment with modulation of spasticity…
  • 2018 International Congress

    Intrathecal baclofen (ITB) therapy in the treatment of severe spasticity: Safety and Product Performance from a Large Multinational Multi-Center Registry

    M. Schiess, S. Eldabe, R. Spencer, K. Stromberg, T. Weaver, R. Plunkett (Houston, TX, USA)

    Objective: •To use real-world registry data to augment available safety data, product performance and support overall efficacy. •To utilize registry data to broaden awareness of…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • #24752 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley